title: Effects of increased dietary cholesterol with carbohydrate restriction on hepatic lipid metabolism in Guinea pigs.
abstract: Excessive lipid accumulation within hepatocytes, or hepatic steatosis, is the pathognominic feature of nonalcoholic fatty liver disease (NAFLD), a disease associated with insulin resistance and obesity. Low-carbohydrate diets (LCD) improve these conditions and were implemented in this study to potentially attenuate hepatic steatosis in hypercholesterolemic guinea pigs. Male guinea pigs (n = 10 per group) were randomly assigned to consume high cholesterol (0.25 g/100 g) in either a LCD or a high-carbohydrate diet (HCD) for 12 wk. As compared with HCD, plasma LDL cholesterol was lower and plasma triglycerides were higher in animals fed the LCD diet, with no differences in plasma free fatty acids or glucose. The most prominent finding was a 40% increase in liver weight in guinea pigs fed the LCD diet despite no differences in hepatic cholesterol or triglycerides between the LCD and the HCD groups. Regardless of diet, all livers had severe hepatic steatosis on histologic examination. Regression analysis suggested that liver weight was independent of body weight and liver mass was independent of hepatic lipid content. LCD livers had more proliferating hepatocytes than did HCD livers, suggesting that in the context of cholesterol-induced hepatic steatosis, dietary carbohydrate restriction enhances liver cell proliferation.
authors.affiliation: Department of Nutritional Sciences, University of Connecticut, Storrs, Connecticut, USA.
authors.forename: Ryan
authors.initials: R
authors.lastname: deOgburn
authors.forename: Jose O
authors.initials: JO
authors.lastname: Leite
authors.forename: Joseph
authors.initials: J
authors.lastname: Ratliff
authors.forename: Jeff S
authors.initials: JS
authors.lastname: Volek
authors.forename: Mary M
authors.initials: MM
authors.lastname: McGrane
authors.forename: Maria Luz
authors.initials: ML
authors.lastname: Fernandez
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D049109:Cell Proliferation; D002791:Cholesterol, Dietary / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D050528:Diet, Carbohydrate-Restricted; D004195:Disease Models, Animal; D004435:Eating; D002149:Energy Intake; D004798:Enzymes / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005234:Fatty Liver / Q000097:blood / Q000209:etiology / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*; D006168:Guinea Pigs; D006937:Hypercholesterolemia / Q000097:blood / Q000150:complications / Q000178:diet therapy* / Q000209:etiology / Q000473:pathology; D008099:Liver / Q000378:metabolism* / Q000473:pathology; D008297:Male; D009929:Organ Size; D012720:Severity of Illness Index; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
chemical_list: D015415:Biomarkers; D001786:Blood Glucose; D002791:Cholesterol, Dietary; D008078:Cholesterol, LDL; D004798:Enzymes; D005230:Fatty Acids, Nonesterified; D014280:Triglycerides